Form 4: ANI Pharmaceuticals SVP, Chief HR Officer, Krista Davis, Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Krista Davis, SVP, Chief HR Officer of ANI Pharmaceuticals, reports the withholding of 1,099 common stock shares for tax purposes related to the vesting of restricted stock on February 28, 2025.
Summary
- On February 28, 2025, Krista Davis, SVP, Chief HR Officer of ANI Pharmaceuticals, had 1,099 shares of common stock withheld for tax purposes.
- The shares were withheld at a price of $61.89 per share.
- This transaction is related to the vesting of 3,039 shares of restricted stock previously reported.
- Following the transaction, Davis beneficially owns 67,525 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (tax withholding) and does not contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax withholding related to the vesting of restricted stock, a common form of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of stock transaction (tax withholding) |
| 03/04/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, ANI Pharmaceuticals, Krista Davis, Stock Transaction, Beneficial Ownership, Tax Withholding, Restricted Stock, ANIP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.